| BE0318-25MG
| InVivoMAb anti-human Ganglioside GD2
| 25 mg
| BioXCell
| in vitro induction of apoptosis in GD2+ cells, in
|
| Mouse
| Human
| Solicitar Precio
|
| BP0087-5MG
| InVivoPlus polyclonal Syrian hamster IgG
| 5 mg
| BioXCell
|
|
| Syrian hamster
| n/
| Solicitar Precio
|
| BP0075-1-5MG
| InVivoPlus anti-mouse Ly6G
| 5 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0317-5MG
| InVivoMAb anti-mouse CD38
| 5 mg
| BioXCell
| in vivo CD38 stimulation, in vitro CD38 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0322-25MG
| InVivoMAb anti-mouse CD172a (SIRP?)
| 25 mg
| BioXCell
| in vivo SIRP? blocking, in vitro SIRP? blocking, W
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0304-25MG
| InVivoMAb anti-mouse BTLA (CD272)
| 25 mg
| BioXCell
| in vivo BTLA+ B cell and CD4 T cell depletion, Flo
|
| Mouse
| Mouse
| Solicitar Precio
|
| BE0299-5MG
| InVivoMAb anti-mouse CD200 (OX2)
| 5 mg
| BioXCell
| in vivo CD200 blockade, in vitro CD200 blockade, I
|
| Rat
| Mouse
| Solicitar Precio
|
| BP0051-100MG
| InVivoPlus anti-mouse IL-12 p40
| 100 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chr
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0308-50MG
| InVivoMAb anti-rat CD4
| 50 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
|
| BE0316-25MG
| InVivoMAb anti-mouse CCR3 (CD193)
| 25 mg
| BioXCell
| in vivo eosinophil depletion
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0300-5MG
| InVivoMAb anti-mouse CD45.2
| 5 mg
| BioXCell
| Flow cytometry, Immunohistochemistry (frozen), in
|
| Mouse
| Mouse
| Solicitar Precio
|
| BE0297-100MG
| InVivoMAb human IgG1 isotype control
| 100 mg
| BioXCell
|
|
| Human
| n/
| Solicitar Precio
|
| BE0323-1MG
| InVivoMAb anti-mouse TL1A (TNFSF15)
| 1 mg
| BioXCell
| in vivo TL1A neutralization, Flow cytometry
|
| Armenian hamster
| Mouse
| Solicitar Precio
|
| BE0311-50MG
| InVivoMAb anti-mouse CD317 (BST2, PDCA-1)
| 50 mg
| BioXCell
| in vivo pDC depletion, Immunofluorescence, Flow cy
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0342-1MG
| InVivoMAb recombinant Flt-3L-Ig (hum/hum)
| 1 mg
| BioXCell
|
|
| n/a
| n/
| Solicitar Precio
|
| BE0349-1MG
| InVivoMAb human IgG4 (S228P) isotype control, anti-hen egg lysozyme
| 1 mg
| BioXCell
|
|
| Human
| he
| Solicitar Precio
|
| BE0307-5MG
| InVivoMAb anti-mouse CD16/CD32
| 5 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0298-25MG
| InVivoMAb anti-mouse CD122 (IL-2R?)
| 25 mg
| BioXCell
| in vivo NK cell depletion, in vitro IL-2R blockade
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0310-25MG
| InVivoMAb anti-mouse VISTA
| 25 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian hamster
| Mouse
| Solicitar Precio
|
| BE0326-50MG
| InVivoMAb anti-mouse IL-27 p28
| 50 mg
| BioXCell
| in vivo IL-27 p28 neutralization, in vitro IL-27 p
|
| Mouse
| Mouse
| Solicitar Precio
|
| BE0311-25MG
| InVivoMAb anti-mouse CD317 (BST2, PDCA-1)
| 25 mg
| BioXCell
| in vivo pDC depletion, Immunofluorescence, Flow cy
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0337-100MG
| InVivoMAb anti-mouse CD96
| 100 mg
| BioXCell
| in vivo CD96 blocking, in vitro CD96 blocking, flo
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0329-50MG
| InVivoMAb anti-mouse CD71 (TfR1)
| 50 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0325-1MG
| InVivoMAb anti-West Nile/dengue virus E protein
| 1 mg
| BioXCell
| Neutralization of WNV, Neutralization of DENV1,2,3
|
| Mouse
| West Nile/dengue viru
| Solicitar Precio
|
| BP0012-100MG
| InVivoPlus anti-mouse CD25 (IL-2R?)
| 100 mg
| BioXCell
| in vivo regulatory T cell depletion, Flow cytometr
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0355-100MG
| InVivoMAb anti-human CA19-9
| 100 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
|
| BP0004-1-5MG
| InVivoPlus anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0337-25MG
| InVivoMAb anti-mouse CD96
| 25 mg
| BioXCell
| in vivo CD96 blocking, in vitro CD96 blocking, flo
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0311-5MG
| InVivoMAb anti-mouse CD317 (BST2, PDCA-1)
| 5 mg
| BioXCell
| in vivo pDC depletion, Immunofluorescence, Flow cy
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0333-1MG
| InVivoMAb anti-mouse/human/rat LRP1 (CD91)
| 1 mg
| BioXCell
| Western blot, Immunofluorescence, Immunoprecipitat
|
| Mouse
| mouse/human/ra
| Solicitar Precio
|
| BE0332-5MG
| InVivoMAb anti-mouse FGL-1
| 5 mg
| BioXCell
| in vivo FGL-1 blockade, in vitro FGL-1 blockade, F
|
| Mouse
| Mouse
| Solicitar Precio
|
| BE0320-100MG
| InVivoMAb anti-mouse Ly6G/Ly6C
| 100 mg
| BioXCell
| in vivo neutrophil depletion, Immunohistochemistry
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0337-50MG
| InVivoMAb anti-mouse CD96
| 50 mg
| BioXCell
| in vivo CD96 blocking, in vitro CD96 blocking, flo
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0344-50MG
| InVivoMAb anti-mouse TIM-4
| 50 mg
| BioXCell
| Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
|
| BP0075-5MG
| InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1)
| 5 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0324-100MG
| InVivoMAb anti-human/mouse denatured collagen type-I (RGD motif)
| 100 mg
| BioXCell
| Western blot, Immunofluorescence, in vivo adminis
|
| Mouse
| human/mous
| Solicitar Precio
|
| BE0320-1MG
| InVivoMAb anti-mouse Ly6G/Ly6C
| 1 mg
| BioXCell
| in vivo neutrophil depletion, Immunohistochemistry
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0329-100MG
| InVivoMAb anti-mouse CD71 (TfR1)
| 100 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0301-1MG
| InVivoMAb human IgG2 isotype control
| 1 mg
| BioXCell
|
|
| Human
| n/
| Solicitar Precio
|
| BE0311-1MG
| InVivoMAb anti-mouse CD317 (BST2, PDCA-1)
| 1 mg
| BioXCell
| in vivo pDC depletion, Immunofluorescence, Flow cy
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0337-5MG
| InVivoMAb anti-mouse CD96
| 5 mg
| BioXCell
| in vivo CD96 blocking, in vitro CD96 blocking, flo
|
| Rat
| Mouse
| Solicitar Precio
|
| BP0055-100MG
| InVivoPlus anti-mouse IFN?
| 100 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0336-5MG
| InVivoMAb anti-human MUC1 (CD227)
| 5 mg
| BioXCell
| in vivo administration in mouse xenograft models,
|
| Mouse
| Human
| Solicitar Precio
|
| BE0300-25MG
| InVivoMAb anti-mouse CD45.2
| 25 mg
| BioXCell
| Flow cytometry, Immunohistochemistry (frozen), in
|
| Mouse
| Mouse
| Solicitar Precio
|
| BE0309-100MG
| InVivoMAb anti-mouse CXCL9 (MIG)
| 100 mg
| BioXCell
| Immunofluorescence
|
| Armenian hamster
| Mouse
| Solicitar Precio
|
| BE0344-5MG
| InVivoMAb anti-mouse TIM-4
| 5 mg
| BioXCell
| Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
|
| BP0012-5MG
| InVivoPlus anti-mouse CD25 (IL-2R?)
| 5 mg
| BioXCell
| in vivo regulatory T cell depletion, Flow cytometr
|
| Rat
| Mouse
| Solicitar Precio
|
| BE0340-100MG
| InVivoMAb anti-human/monkey MDR-1 (CD243)
| 100 mg
| BioXCell
| in vivo MDR-1 blocking/depletion in xenogeneic mur
|
| Mouse
| human/monke
| Solicitar Precio
|
| BE0331-1MG
| InVivoMAb anti-rat/mouse CD71 (TfR1)
| 1 mg
| BioXCell
| Targeted drug delivery to the brain, Immunohistoch
|
| Mouse
| rat/mous
| Solicitar Precio
|
| BE0327-50MG
| InVivoMAb anti-human IL-9
| 50 mg
| BioXCell
| Flow cytometry, ELISA
|
| Mouse
| Human
| Solicitar Precio
|